Sciacovelli Marco, Frezza Christian
Medical Research Council Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge CB2 0XZ, United Kingdom.
Medical Research Council Cancer Unit, University of Cambridge, Hutchison/MRC Research Centre, Box 197, Cambridge Biomedical Campus, Cambridge CB2 0XZ, United Kingdom.
Free Radic Biol Med. 2016 Nov;100:175-181. doi: 10.1016/j.freeradbiomed.2016.04.025. Epub 2016 Apr 23.
Cancer is a complex and heterogeneous disease thought to be caused by multiple genetic lesions. The recent finding that enzymes of the tricarboxylic acid (TCA) cycle are mutated in cancer rekindled the hypothesis that altered metabolism might also have a role in cellular transformation. Attempts to link mitochondrial dysfunction to cancer uncovered the unexpected role of small molecule metabolites, now known as oncometabolites, in tumorigenesis. In this review, we describe how oncometabolites can contribute to tumorigenesis. We propose that lesions of oncogenes and tumour suppressors are only one of the possible routes to tumorigenesis, which include accumulation of oncometabolites triggered by environmental cues.
癌症是一种复杂的异质性疾病,被认为是由多种基因损伤引起的。最近发现三羧酸(TCA)循环中的酶在癌症中发生突变,这重新引发了一种假说,即代谢改变可能在细胞转化中也起作用。将线粒体功能障碍与癌症联系起来的尝试揭示了小分子代谢物(现在称为肿瘤代谢物)在肿瘤发生中的意外作用。在这篇综述中,我们描述了肿瘤代谢物如何促进肿瘤发生。我们提出,癌基因和肿瘤抑制因子的损伤只是肿瘤发生的可能途径之一,其中包括由环境线索触发的肿瘤代谢物的积累。